Clinical Trial Update: Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia [Phase 2, Phase 3]

View source ↗

Summary

An update on a Phase 2/Phase 3 clinical trial evaluating the effect of an antioxidant on oxidant status in immune thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Antioxidant

Snippet

Sponsor: Ain Shams University | Conditions: Immune Thrombocytopenia | Phase 2, Phase 3 | Status: UNKNOWN